Drug Profile


Alternative Names: Diclofenac-menthol; Menthol/diclofenac; MFC 51123

Latest Information Update: 19 May 2015

Price : $50

At a glance

  • Originator GlaxoSmithKline
  • Class Cyclohexanols; Monoterpenes; Non-opioid analgesics; Nonsteroidal anti-inflammatories; Phenylacetates; Small molecules
  • Mechanism of Action Cyclooxygenase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • On Fast track

    Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.

  • New Molecular Entity No

Highest Development Phases

  • Phase III Pain

Most Recent Events

  • 01 Mar 2015 GlaxoSmithKline completes a phase III trial in Pain in Germany (NCT02100670)
  • 01 Nov 2014 GlaxoSmithKline completes a phase I trial in Healthy volunteers in USA (NCT02201238)
  • 01 Oct 2014 GlaxoSmithKline initiates a phase I trial in Healthy volunteers in USA (NCT02201238)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top